The overseas arm of Hendersonville-based Smith Travel Research has been awarded the contract to survey the state of Australia's smaller lodging and hospitality properties. STR Global will take stock of 6,000 hotels, motels, hostels, serviced apartments and guest houses with less than 15 rooms and caravan parks. The goal is to give the industry and policy makers better info about a tourism sector segment that has gone under the radar.

BioMimetic Therapeutics has recieved the regulatory go ahead to commercialize its Augment Bone Graft in Australia.

the Therapeutic Goods Administration (TGA) has approved the Company’s medical device application for Augment^® Bone Graft clearing the way for commercialization of the product in Australia and its listing on the Australian Register of Therapeutic Goods (ARTG). Based on the clinical data from the North American pivotal trial and Canadian registration trial evaluating Augment Bone Graft, the product has been approved in Australia for use as an alternative to autograft, the current gold standard in bone grafting

The company's stock (Ticker: BMTI) has seen a big pop from the news rising 11 percent to $3.33 in early morning trading.

Ingram Content Group this morning said that Melbourne will be the location of its Lightning Source print-on-demand book manufacturing operation in Australia. The company announced plans in September to set up shop in the country.

The operation, expected to open in June 2011, will be Ingram Content's fifth networked book manufacturing facility. The company selected the location for its proximity to a large concentration of major book publishers and distributors and to key metropolitan regions in the country.

“The addition of a new manufacturing facility will have a significant impact on publishers, the retail book trade and ultimately consumers,” said David “Skip” Prichard, President and CEO, Ingram Content Group. “At Ingram, we are pleased to expand our leading print and distribution network to the Asia Pacific market, helping more content reach more destinations around the world. We will continue to make investments that fit the future of book distribution, whether traditional, print on demand, or digital.”

The company's other Lightning Source facilities include its headquarters in La Vergne, and operations in Pennsylvania, the United Kingdom and France.

"Acetadote has become a standard of care for treating acetaminophen poisoning in the U.S., and we are proud to work with Phebra to extend the product's benefits to the Australian medical community," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "Phebra's established distribution network and marketing experience with more than 70 hospital products gives us confidence in its ability to make this life-saving drug available to a broad audience. We are also extremely pleased to mark Cumberland's entry into international markets with this important product launch."

“I am thrilled with the relationship that Vanderbilt enjoys with the University of Melbourne. It is one of the leading universities in the world and our partnership will strengthen both institutions across a range of areas. Our colleagues from Melbourne are remarkable for their talents, their energy and their commitment to excellence in all that they undertake,” said Richard McCarty, Vanderbilt provost and vice chancellor for Academic Affairs.

“The expansion of our Lightning Source global print solution into Australia is a significant step in the ongoing mission of Ingram Content Group to help content reach its destination swiftly and efficiently to retailers and readers worldwide,” said David “Skip” Prichard, President and CEO of Ingram Content Group. “This expansion of Ingram’s global presence, from the United Kingdom to France and now Australia, provides publishers with expanded market reach and sales opportunities, as well as makes thousands of books available quickly and affordably to booksellers and their customers.”